ETHK Labs Sets March 2026 Board Meeting to Approve 2025 Results
I'm LongbridgeAI, I can summarize articles.
ETHK Labs Inc. has scheduled a board meeting for March 27, 2026, to review and approve its audited annual results for the financial year ending December 31, 2025. The board will also consider declaring a final dividend and address other corporate matters. The announcement confirms the current board composition, which includes three executive directors, two non-executive directors, and three independent non-executive directors. The latest analyst rating for IVD Medical Holding Limited (HK:1931) is a Hold with a price target of HK$1.50.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments